- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| VIRAX BIOLABS GROUP Aktie jetzt für 0€ handeln | |||||
| 26.05. | Virax reports early pilot data for long COVID blood test | 3 | Investing.com | ||
| 26.05. | Virax BioLabs Group Limited: Virax Biolabs Reports Positive Early Clinical Data for ViraxImmune in Long COVID and Related Post-Acute Infection Syndromes | 445 | PR Newswire | LONDON, May 26, 2026 /PRNewswire/ -- Virax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company") today reported positive early pilot performance data... ► Artikel lesen | |
| 22.05. | Virax Biolabs Group Ltd - 6-K, Report of foreign issuer | 4 | SEC Filings | ||
| 19.05. | Why Is Virax Biolabs (VRAX) Stock Trending Overnight? | 2 | Benzinga.com | ||
| 15.05. | RedChip Companies, Inc.: Avalon Advanced Materials and Virax Biolabs Interviews to Air on the RedChip Small Stocks, Big Money Show on Bloomberg TV | 416 | ACCESS Newswire | ORLANDO, FL / ACCESS Newswire / May 15, 2026 / RedChip Companies will air interviews with Avalon Advanced Materials Inc. (OTCQB:AVLNF)(TSX:AVL) and Virax Biolabs Group Limited (Nasdaq:VRAX) on the RedChip... ► Artikel lesen | |
| 11.05. | Virax Mulls Bringing UK Biotech Startup's Immune Profiling Platform to China, Chair Says | 1 | Yicai Global | ||
| 10.04. | Virax Biolabs Group Ltd - 6-K, Report of foreign issuer | 4 | SEC Filings | ||
| 31.03. | Virax Biolabs-Tochter erhält ISO-Qualitätszertifizierungen | 2 | Investing.com Deutsch | ||
| 31.03. | Virax BioLabs Group Limited: Virax Biolabs Achieves ISO Certifications, Laying Foundation for Regulated IVD Development and U.S. Clinical Validation | 157 | PR Newswire | LONDON, March 31, 2026 /PRNewswire/ -- Virax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company") today announced that Virax Biolabs (UK) Limited, its... ► Artikel lesen | |
| 30.01. | Virax Biolabs Group Ltd - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 12.01. | H.C. Wainwright senkt Kursziel für Virax Biolabs auf 1 US-Dollar | 2 | Investing.com Deutsch | ||
| 12.01. | Virax Biolabs stock price target lowered to $1 at H.C. Wainwright | 1 | Investing.com | ||
| 03.11.25 | Virax BioLabs Group Limited: Virax Biolabs Completes UK Clinical Recruitment and Reports Constructive FDA Feedback for ViraxImmune Study Evaluating T Cell Dysfunction in Post-Acute Infection Syndromes | 315 | PR Newswire | LONDON, Nov. 3, 2025 /PRNewswire/ -- Virax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company"), an innovative biotechnology company focused on the detection... ► Artikel lesen | |
| 26.08.25 | Virax BioLabs Group Limited: Virax Biolabs Partners with Emory University on ViraxImmune Clinical Studies; Readies for FDA Pre-Submission Meeting in Early September | 322 | PR Newswire | LONDON, Aug. 26, 2025 /PRNewswire/ -- Virax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company"), an innovative biotechnology company focused on immune... ► Artikel lesen | |
| 18.07.25 | Virax BioLabs Group Limited: Virax Biolabs Announces Receipt of NASDAQ Notification Letter Regarding Minimum Bid Price Deficiency | 351 | PR Newswire | LONDON, July 18, 2025 /PRNewswire/ -- Virax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company"), an innovative biotechnology company focused on the... ► Artikel lesen |
15 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BIONTECH | 77,05 | -1,34 % | BioNTech mit neuen Daten - doch reicht das? | BioNTech und der Partner Bristol Myers Squibb haben am Wochenende auf dem ASCO-Meeting in Chicago neue Zwischenergebnisse der Phase-2/3-Studie ROSETTA-Lung-02 veröffentlicht. Untersucht wird dabei der... ► Artikel lesen | |
| EVOTEC | 4,932 | -3,58 % | Evotec holt KI-Manager von AstraZeneca | Evotec verstärkt den Bereich Künstliche Intelligenz und computergestützte Forschung mit einem erfahrenen Branchenmanager. Rui Wang übernimmt die neu geschaffene Position des Head of Global In Silico... ► Artikel lesen | |
| MODERNA | 41,190 | +0,12 % | Neue CAR-T-Erfolge bei Autoimmunerkrankungen: Warum Lösungen für Zelltherapien vor dem nächsten Wachstumsschub stehen könnten | ||
| BIOGEN | 171,56 | +1,19 % | Biogen's Salanersen Wins FDA Breakthrough Therapy Designation For Spinal Muscular Atrophy Treatment | WESTON (dpa-AFX) - Thursday, Biogen Inc. (BIIB) announced that the U.S. Food and Drug Administration has granted salanersen Breakthrough Therapy Designation for the treatment of spinal muscular... ► Artikel lesen | |
| ILLUMINA | 139,80 | -0,70 % | ILMN Stock Jumps 98.7% in a Year: What's Powering the Surge? | ||
| CRISPR THERAPEUTICS | 44,705 | -0,60 % | CRISPR Therapeutics AG (CRSP): One of The most Shorted Mid Cap Stocks to Buy on Robust Gene Editing Pipeline | ||
| VIKING THERAPEUTICS | 24,650 | -0,20 % | XETR NEW INSTRUMENTS AVAILABLE ON XETRA - 04.06.2026 | Folgende Wertpapiere werden in den Handel an folgenden Handelsplätzen (MIC Code) im Quotation Board an der Frankfurter Wertpapierbörse (FWB) aufgenommen. Die Notierung an anderen Handelsplätzen im Quotation... ► Artikel lesen | |
| ATAIBECKLEY | 3,400 | -0,58 % | AtaiBeckley Inc. - 8-K, Current Report | ||
| ASEP MEDICAL | 0,100 | 0,00 % | CSE Bulletin: Suspensions - VSBLTY Groupe Technologies Corp., NuRAN Wireless Inc., GOAT Industries Ltd., BYT Holdings Ltd., ASEP Medical Holdings Inc., BioVaxys Technology Corp. | Le 6 mai/May 2026
Effective immediately, the following companies are suspended pursuant to CSE Policy 3. The suspensions are considered Regulatory Halts as defined in National Instrument 23-101 Trading... ► Artikel lesen | |
| GINKGO BIOWORKS | 6,904 | -2,90 % | Ginkgo Bioworks Reports First Quarter 2026 Financial Results, Completes Divestiture of Biosecurity and Continues to Scale Autonomous Lab | Ginkgo provides an update on its first quarter financial results following the divestiture of its Biosecurity business
BOSTON, May 7, 2026 /PRNewswire/ -- Ginkgo... ► Artikel lesen | |
| TWIST BIOSCIENCE | 60,88 | +1,43 % | LenioBio GmbH: LenioBio and Twist Bioscience Enter into a Collaboration to Further Enable AI drug-discovery | LenioBio GmbH, a TechBio company commercializing its ALiCE cell-free protein expression platform, today announced a collaborative agreement with Twist Bioscience Corporation. The collaboration will... ► Artikel lesen | |
| OCULAR THERAPEUTIX | 7,150 | -0,69 % | Ocular Therapeutix, Inc.: Ocular Therapeutix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | ||
| AGIOS | 24,600 | 0,00 % | Agios Pharmaceuticals, Inc.: Agios Enters Exclusive Global License Agreement with Oscotec to Develop and Commercialize Next-Generation SYK Inhibitor Cevidoplenib | Agios obtains exclusive global rights to novel, late-stage, next-generation, oral SYK inhibitor Agreement diversifies Agios' rare hematology portfolio with expansion into immune thrombocytopenia,... ► Artikel lesen | |
| BIOXCEL THERAPEUTICS | 0,980 | +2,08 % | BioXcel Therapeutics Provides Business Update and Reports First Quarter 2026 Financial Results | FDA accepted sNDA for IGALMI® use in at-home (outpatient) setting; set Nov. 14, 2026, as PDUFA date Advancing BXCL501 as a potential acute treatment for agitation associated with Alzheimer's dementia... ► Artikel lesen | |
| GENPREX | 0,655 | +1,22 % | Genprex, Inc.: Genprex Strengthens Intellectual Property Portfolio with Japanese and EU Patents for Reqorsa Gene Therapy in Combination with Immunotherapies to Treat Cancer | Japanese Patent Covers Acclaim-3 Clinical Trial Combining REQORSA Gene Therapy with Genentech, Inc.'sTecentriq®
AUSTIN, Texas, Feb. 23, 2026 /PRNewswire/ -- Genprex... ► Artikel lesen |
Das Unternehmen VIRAX BIOLABS GROUP LIMITED kann der Branche Biotechnologie zugeordnet werden. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 0,213 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu VIRAX BIOLABS GROUP LIMITED finden Sie auf Wallstreet Online.